Drug recall · November 23, 2016
FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit recall
Why: Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 3 OZ, Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-03
- Lots / codes
Lot #: E1396, Exp. 08/2018
- Quantity
- 5904 kits
- Company
- CutisPharma, Inc., Wilmington, MA
- Distribution
- Nationwide
- Initiated
- October 20, 2016 · Voluntary: Firm initiated
- Classified
- November 16, 2016
- Reported
- November 23, 2016
- Ended
- September 12, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Omeprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.